We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
Cap. Flow
-$392M
Cap. Flow %
-6.36%
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$100M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$97M
3
LRCX icon
Lam Research
LRCX
+$85.4M
4
BSX icon
Boston Scientific
BSX
+$79.4M
5
MRK icon
Merck
MRK
+$67M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$145M
2
ASML icon
ASML
ASML
+$119M
3
QRVO icon
Qorvo
QRVO
+$89M
4
MSFT icon
Microsoft
MSFT
+$82.9M
5
ISRG icon
Intuitive Surgical
ISRG
+$75.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.56%
2 Technology 29.01%
3 Industrials 8.79%
4 Communication Services 5.99%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KLAQ
401
DELISTED
KL Acquisition Corp Class A Common Stock
KLAQ
$1.85M 0.03%
189,155
– –
EPZM
402
DELISTED
Epizyme, Inc
EPZM
$1.73M 0.03%
+1,500,000
New +$2.45M
TZPS
403
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
$1.72M 0.03%
175,000
– –
VPCB
404
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
$1.71M 0.03%
175,000
– –
BURL icon
405
Burlington
BURL
$23.4B
$1.69M 0.03%
+9,291
New +$2.04M
QDRO
406
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
$1.69M 0.03%
172,066
– –
SV
407
DELISTED
Spring Valley Acquisition Corp. Class A Ordinary Share
SV
$1.65M 0.03%
157,810
– –
VTYX
408
DELISTED
Ventyx Biosciences
VTYX
$1.63M 0.03%
120,000
– –
SWAV
409
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$1.62M 0.03%
+7,815
New +$1.29M
TBIO
410
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$1.61M 0.03%
16,671
-7,991
-32% -$1.21M
BPMC
411
DELISTED
Blueprint Medicines
BPMC
$1.59M 0.03%
24,873
-37,182
-60% -$2.67M
ARYD
412
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$1.54M 0.02%
156,880
– –
LENZ
413
LENZ Therapeutics
LENZ
$164M
$1.53M 0.02%
42,862
– –
IRAA
414
DELISTED
Iris Acquisition Corp Class A Common Stock
IRAA
$1.51M 0.02%
154,698
– –
CITE
415
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$1.5M 0.02%
+150,000
New +$1.49M
PHYT
416
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$1.49M 0.02%
+150,000
New +$1.49M
PPYA
417
DELISTED
Papaya Growth Opportunity Corp. I Class A Common Stock
PPYA
$1.49M 0.02%
+150,000
New +$1.49M
ABP
418
DELISTED
Abpro Holdings
ABP
$1.49M 0.02%
+5,000
New +$1.49M
HAIA
419
DELISTED
Healthcare AI Acquisition Corp. Class A Ordinary Shares
HAIA
$1.49M 0.02%
+150,000
New +$1.48M
SOAR icon
420
Volato Group
SOAR
$6.89M
$1.49M 0.02%
+6,000
New +$1.48M
BTMD icon
421
Biote Corp
BTMD
$49.4M
$1.48M 0.02%
150,000
– –
RJAC
422
DELISTED
Jackson Acquisition Company
RJAC
$1.48M 0.02%
+150,000
New +$1.48M
SUAC
423
DELISTED
ShoulderUp Technology Acquisition Corp.
SUAC
$1.48M 0.02%
+150,000
New +$1.48M
ZING
424
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
$1.48M 0.02%
+150,000
New +$1.47M
POW
425
DELISTED
Powered Brands Class A Ordinary Shares
POW
$1.48M 0.02%
150,000
– –
15 16
17
18 19

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.

  • Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
  • Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
  • Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
  • Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
  • Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
  • Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.